title: Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist.
abstract: SR 48968, a new non-peptide antagonist of NK2 receptors, has been tested in a variety of isolated smooth muscle preparations from rats, guinea pigs, rabbits, hamsters and men, in order to assess its selectivity for NK2 receptors as well as its competitivity and specificity. The compound has been found to be inactive as a stimulant or relaxant in all preparations but to exert a potent, competitive antagonism, particularly in tissues obtained from rabbits (pA2 9.8-10.3), guinea pigs (10.5), rats (9.4-9.6), men (9.36-9.6) and hamsters (7.45-8.6). SR 48968 is therefore more active on the NK2A than on the NK2B receptor subtype and the human receptor is close to the NK2A subtype. SR 48968 exerts an antagonism of the competitive type and is therefore suitable for receptor classification despite its slow reversibility in vitro. The sensitivity of NK2A receptors to SR 48968 is at least 1000 times higher than those of NK1 and NK3 receptors. The compound does not affect the effects of bradykinin, angiotensin or bombesin. Because of its activity in human tissues, its potency and long duration of action, SR 48968 is a new promising pharmacologic and possibly therapeutic agent.
authors.affiliation: Faculté de Médecine Paris-Ouest, Ecole de Médecine, France.
authors.forename: C
authors.initials: C
authors.lastname: Advenier
authors.forename: N
authors.initials: N
authors.lastname: Rouissi
authors.forename: Q T
authors.initials: QT
authors.lastname: Nguyen
authors.forename: X
authors.initials: X
authors.lastname: Emonds-Alt
authors.forename: J C
authors.initials: JC
authors.lastname: Breliere
authors.forename: G
authors.initials: G
authors.lastname: Neliat
authors.forename: E
authors.initials: E
authors.lastname: Naline
authors.forename: D
authors.initials: D
authors.lastname: Regoli
mesh_terms: D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007537:Isometric Contraction / Q000187:drug effects*; D008297:Male; D008647:Mesocricetus; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D015288:Neurokinin A / Q000037:antagonists & inhibitors / Q000378:metabolism; D009928:Organ Specificity; D010880:Piperidines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D018041:Receptors, Neurokinin-2; D017981:Receptors, Neurotransmitter / Q000037:antagonists & inhibitors* / Q000502:physiology; D013045:Species Specificity
chemical_list: D001549:Benzamides; D010880:Piperidines; D018041:Receptors, Neurokinin-2; D017981:Receptors, Neurotransmitter; C073839:SR 48968; D015288:Neurokinin A